Wound - Nursing Case Study

Pathophysiology

• Primary mechanism: Tissue Disruption - Wounds result from a break in the skin's integrity, leading to exposure of underlying tissues and potential entry points for pathogens, initiating an inflammatory response crucial for wound healing.

• Secondary mechanism: Inflammatory Response - Triggered by tissue injury, this involves the release of cytokines and recruitment of immune cells to the site, essential for debris clearance and infection prevention, but excessive inflammation can impede healing.

• Key complication: Impaired Healing - Factors such as infection, poor circulation, or chronic inflammation can delay wound closure, leading to chronic wounds or ulcers, necessitating careful monitoring and management to prevent further deterioration.

Patient Profile

Demographics:

42-year-old female, construction worker

History:

• Key past medical history: Type 2 Diabetes, Hypertension

• Current medications: Metformin, Lisinopril, Ibuprofen

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Infected wound on left forearm

• Key symptoms: Redness, swelling, warmth at the site, purulent discharge, mild fever, increasing pain

• Vital signs: Temperature 100.4°F, Blood Pressure 142/88 mmHg, Heart Rate 96 bpm, Respiratory Rate 20 breaths per minute

Section 1

New Complications:

Upon reevaluation three days post initial presentation, the patient exhibits signs of developing complications. The wound on the left forearm has increased in size and depth, with the surrounding tissue showing heightened erythema extending beyond the original margins. The purulent discharge has become more copious, and the odor has intensified, suggesting a potential progression to a more severe infection, possibly cellulitis or an early-stage abscess. The patient's temperature has risen to 101.2°F, indicating a systemic inflammatory response, and her heart rate has increased to 104 bpm. These changes warrant further investigation to rule out sepsis and to assess the extent of tissue involvement.

Lab results reveal a significant leukocytosis with a white blood cell count of 15,500/mm³, indicating an acute inflammatory response, likely due to bacterial infection. C-reactive protein levels are elevated, further supporting active inflammation. Given the patient's history of Type 2 Diabetes, there is concern for impaired immune response and delayed wound healing, which are exacerbated by the hyperglycemic environment. Blood glucose levels are noted at 180 mg/dL despite adherence to prescribed Metformin, suggesting the need for tighter glycemic control to aid in the wound healing process.

These findings necessitate a multidisciplinary approach involving infectious disease consultation for potential intravenous antibiotic therapy, wound care specialists for debridement considerations, and endocrinology input for diabetes management. The clinical team must carefully balance interventions to address the infection, control systemic inflammatory response, and optimize conditions for wound healing while monitoring for any signs of further complications, such as osteomyelitis or systemic infection.

Section 2

New Diagnostic Results:

Following the multidisciplinary consultation, the clinical team proceeded with additional diagnostic studies to further elucidate the extent of the infection and potential complications. An ultrasound of the left forearm was performed to evaluate the depth and nature of the wound and surrounding tissues. The imaging revealed a small, localized fluid collection suggestive of an early-stage abscess, confirming the need for potential drainage. In addition, the ultrasound showed increased subcutaneous edema and fascial thickening, raising concerns about the spread of infection and possible early-stage cellulitis.

Blood cultures were obtained to identify the causative organism and tailor antibiotic therapy. Preliminary results indicated the growth of gram-positive cocci, raising suspicion for Staphylococcus aureus, a common pathogen associated with diabetic wound infections. Sensitivity testing is underway to determine the most effective antibiotic regimen. Given the patient's elevated C-reactive protein and persistent leukocytosis, the infectious disease specialist recommended initiating broad-spectrum intravenous antibiotics, including Vancomycin, to cover methicillin-resistant Staphylococcus aureus (MRSA), while awaiting definitive culture results.

The endocrinology team recommended intensifying glycemic control measures to aid in wound healing and immune response. Adjustments were made to the patient's diabetes management plan, including the introduction of a basal-bolus insulin regimen to achieve tighter glucose control, targeting fasting blood glucose levels between 100-130 mg/dL. The clinical team continues to monitor the patient closely for changes in vital signs and wound appearance, with a plan to reassess the patient's response to the interventions within 48 hours. This strategic approach aims to address the infection aggressively while mitigating the risk of further complications such as osteomyelitis or systemic sepsis.

Section 3

Two days after the implementation of the new interventions, the patient's clinical status demonstrated both encouraging signs and areas of concern. The wound drainage procedure was performed successfully, yielding approximately 10 mL of purulent fluid. Initial cultures of the drainage confirmed the presence of methicillin-susceptible Staphylococcus aureus (MSSA), prompting a switch from Vancomycin to Cefazolin to streamline antibiotic therapy. Despite these actions, the patient continued to experience low-grade fevers, with temperatures fluctuating between 100.4°F and 101.2°F, suggesting a persistent inflammatory response.

On physical examination, the patient reported increased pain and warmth around the wound site, although erythema had not significantly expanded. The edema appeared slightly reduced, and there was no sign of systemic sepsis, as evidenced by stable vital signs: blood pressure at 128/76 mmHg, heart rate at 88 bpm, and respiratory rate at 18 breaths per minute. However, lab results showed a persistently elevated white blood cell count at 14,500/μL, with a slight left shift, indicating ongoing infection or inflammation.

The endocrinology assessment revealed modest improvements in glycemic control, with fasting blood glucose readings consistently in the range of 120-140 mg/dL. Despite these efforts, the potential for complications such as deep tissue involvement or progression to osteomyelitis remained a concern. The interdisciplinary team decided to obtain a follow-up MRI to assess for any deeper extension of the infection and to continue close monitoring of the patient's clinical status. This decision aimed to ensure timely identification and management of any new complications, while maintaining a comprehensive approach to the patient's overall health and recovery trajectory.

Section 4

Two days after the switch to Cefazolin and the implementation of targeted wound care strategies, the patient’s condition presented with a mixed clinical picture, prompting further investigation. The follow-up MRI revealed early signs of soft tissue involvement extending beyond the initial wound site. Although there was no definitive evidence of osteomyelitis at this stage, the proximity of the infection to the bone highlighted the urgency for aggressive management to prevent further complications. The interdisciplinary team, including infectious disease specialists and wound care nurses, emphasized the importance of meticulous wound management and adherence to the antibiotic regimen to contain the infection.

Clinically, the patient began to exhibit subtle signs of systemic response to the ongoing infection. Although vital signs remained stable, the patient reported increased fatigue and malaise, with occasional episodes of chills. The low-grade fever persisted, which, along with the elevated white blood cell count and left shift, suggested that the inflammatory process was not yet adequately controlled. The wound itself, while slightly reduced in edema, displayed increased purulent discharge, indicating that the infection was still active. These findings necessitated a reassessment of the current treatment plan, with consideration given to extending the duration of antibiotic therapy and possibly consulting a surgeon for further evaluation.

In light of these developments, the care team decided to intensify the wound care regimen, incorporating advanced dressings with antimicrobial properties to limit bacterial load. Additionally, they scheduled more frequent wound assessments to closely monitor changes in the wound’s appearance and drainage characteristics. The patient's nutritional status and glycemic control were also highlighted as critical factors in supporting the healing process, prompting a multidisciplinary focus on dietary interventions and diabetes management. The team remained vigilant, recognizing the potential for further complications and the need for a dynamic, responsive approach to the patient’s evolving clinical needs.

Section 5

As the days progressed, the patient began to exhibit a change in status that warranted immediate clinical attention. Despite intensive wound care and adherence to the antibiotic regimen, the patient's systemic symptoms began to worsen. The patient reported increased fatigue and more frequent episodes of chills, now accompanied by night sweats. A reassessment of vital signs revealed a low-grade fever persisting at 100.5°F, a heart rate elevated to 110 beats per minute, and a respiratory rate of 24 breaths per minute. Although blood pressure remained within normal limits, these changes indicated a potential escalation in the patient’s systemic response to the infection.

Laboratory results provided further insight into the patient's condition. The white blood cell count increased to 16,000/mm³ with a notable left shift, suggesting a heightened inflammatory response. C-reactive protein (CRP) levels were also elevated, confirming the presence of ongoing inflammation. The wound itself, while showing some reduction in size, continued to produce purulent discharge with a faint foul odor, raising concerns about the presence of a more resistant bacterial strain or a secondary infection. These findings prompted the care team to reconsider the effectiveness of the current antibiotic therapy, leading to a discussion about the possible need for broadening the antimicrobial coverage or performing a repeat culture to reassess the microbial flora.

In response to the evolving clinical picture, the interdisciplinary team decided to enhance the patient’s treatment strategy. A broader-spectrum antibiotic was initiated to cover potential resistant organisms, and a surgical consultation was requested to evaluate the need for potential debridement or other surgical interventions. Additionally, the team intensified focus on optimizing the patient’s nutritional intake, ensuring adequate protein and caloric consumption to support the healing process. Glycemic control was closely monitored, with adjustments made to the patient’s insulin regimen as necessary. This comprehensive approach aimed to address both the local wound infection and the systemic implications of the patient’s condition, setting the stage for further evaluation and management in the coming days.